The news may have come as a surprise, but it probably shouldn't have. A bioethics expert walks through how big a deal this announcement is – and what we should be considering now.
A new evolutionary perspective on what's been a medical paradox: Why does the body use inflammation to regulate aspects of pregnancy when inflammation is also a big threat to pregnancy?
Women will now be better informed when it comes to deciding whether it's worth undergoing another round of IVF.
Women have been getting their fallopian tubes flushed for 100 years to help them conceive. Studies show it works, all the better if you use an oil-based liquid.
The court found that parents have a strong interest in a "genetic affinity" with their children, one that can merit compensation if subverted.
A twins study shows that children born via IVF have similar epigenetic changes compared with those born naturally.
From today, more people conceived with donor sperm or eggs in Victoria will have the legal right to know details about their donor – even if the donation was made anonymously.
Stem-cell scientists have to work within many limitations placed on their research. One of these is the 14-day rule that outlaws research on pure human embryos over two weeks old.
Health benefits come with regular sexual contact with the same male partner before pregnancy commences.
Medical tourism for assisted reproductive technologies raises a host of legal and ethical questions.
Our recent audit of success rates provided on the websites of IVF clinics’ in Australia and New Zealand identified some common traps in the way these figures are presented.
While most people might think age only affects female fertility, there is growing evidence sperm quality decreases as men age.
In pregnancy, immune cells help the uterus tolerate and nurture the embryo despite it carrying foreign genes from the father. In most women, suppressing immunity will likely cause more harm than good.
Fertility treatment in older age might be tougher, but that doesn't mean it shouldn't be done.
Researchers from Kyushu University, Japan, are the first to turn mice stem cells into mature eggs that can be fertilised.
Early studies suggest a process called advanced in-vitro maturation may be able to treat infertility without women needing to inject themselves with high doses of hormones for several weeks.
Why can we choose some things and not others?
Assisted reproductive technology is a highly profitable global industry, with fertility clinics increasingly being regarded as an attractive investment option.
Most women will have been made aware they have a ticking biological clock. But most probably don't know it's because women are born with a limited supply of eggs, and eventually they will run out.
Government support for infertility treatment is approximately A$240 million a year. The question of whether it's worth it is a complex one.